English | 繁體

Search in the results

UM

Browse/Search Results:  1-2 of 2 Help

Selected(0)Clear Items/Page:    Sort:
Icaritin suppresses development of neuroendocrine differentiation of prostate cancer through inhibition of IL-6/STAT3 and Aurora kinase A pathways in TRAMP mice Journal article
Sun F., Zhang Z.W., Tan E.M., Lim Z.L.R., Li Y., Wang X.C., Chua S.E., Li J., Cheung E., Yong E.-L.. Icaritin suppresses development of neuroendocrine differentiation of prostate cancer through inhibition of IL-6/STAT3 and Aurora kinase A pathways in TRAMP mice[J]. Carcinogenesis, 2016, 37(7), 701-711.
Authors:  Sun F.;  Zhang Z.W.;  Tan E.M.;  Lim Z.L.R.;  Li Y.; et al.
Favorite | TC[WOS]:31 TC[Scopus]:29 | Submit date：2018/12/17
A novel prostate cancer therapeutic strategy using icaritin-activated arylhydrocarbon-receptor to co-target androgen receptor and its splice variants Journal article
Sun F., Indran I.R., Zhang Z.W., Tan M.H.E., Li Y., Lim Z.L.R., Hua R., Yang C., Soon F.-F., Li J., Xu H.E., Cheung E., Yong E.-L.. A novel prostate cancer therapeutic strategy using icaritin-activated arylhydrocarbon-receptor to co-target androgen receptor and its splice variants[J]. Carcinogenesis, 2015, 36(7), 757-768.
Authors:  Sun F.;  Indran I.R.;  Zhang Z.W.;  Tan M.H.E.;  Li Y.; et al.
Favorite | TC[WOS]:53 TC[Scopus]:60 | Submit date：2018/12/17